Medicine guide
EMTRICITABINE TENOFOVIR DISOPROXIL MYLAN 200 mg/245 mg
As listed in the register: EMTRICITABINE TENOFOVIR DISOPROXIL MYLAN 200 mg/245 mg, comprimé pelliculé
200 mg · comprimé pelliculé
- Prescription only
- Active substance
- Maléate De Ténofovir Disoproxil + Emtricitabine
- Made by
- MYLAN PHARMACEUTICALS (IRLANDE)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | MYLAN PHARMACEUTICALS (IRLANDE) |
|---|---|
| Active substance | Maléate De Ténofovir Disoproxil + Emtricitabine |
| Strength | 200 mg |
| Form | comprimé pelliculé |
| Route | orale |
| Dispensing (as stated by the register) | liste I |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/16/1133 |
| Name in the register | EMTRICITABINE TENOFOVIR DISOPROXIL MYLAN 200 mg/245 mg, comprimé pelliculé |
| Packs | 30 plaquette(s) aluminium de 1 comprimé(s) · 30 plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 1 comprimé(s) · 3 flacons polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 30 comprimés (conditionnement multiple) |
| CIS | 65271985 |
| CIP13 | 3400930079034 |
| CIP13 | 3400930254288 |
| CIP13 | 3400930270394 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).